Skip to main content
DH

Dottie Health

Dottie provides automated patient guidance through a digital platform, sending personalized reminders and answering common questions to improve treatment adherence. This reduces the burden on clinical staff and helps patients better manage their care plans.

San Francisco, United States110+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Patients often struggle to adhere to complex treatment plans due to lack of clear guidance, forgotten instructions, and difficulty accessing timely support. This leads to increased healthcare costs, reduced treatment effectiveness, and frustration for both patients and clinical staff.

Solution

Dottie is a digital platform designed to improve patient adherence by providing automated, personalized guidance throughout their care journey. The platform delivers reminders, answers frequently asked questions with responses from the care team, and tracks patient progress. By offering a single point of access for information and support, Dottie reduces the burden on clinical staff, empowers patients to better manage their care, and facilitates more effective communication between patients and providers.

Target Audience

Dottie is targeted towards healthcare providers, hospitals, and insurance companies seeking to improve patient adherence, reduce administrative burden, and enhance patient satisfaction.

Features

  • Personalized reminders for medication, appointments, and other care-related tasks
  • AI-powered chatbot that answers common patient questions using pre-approved responses from the care team
  • Progress tracking tools that allow patients to monitor their adherence and identify potential issues
  • Secure video chat functionality for direct communication with healthcare providers
  • Care comparison tools to help patients understand and compare healthcare costs across different providers and plans
This profile is AI-generated and may contain inaccuracies.